Interestingly, there is a marked increase in galectin-3 mRNA in the same samples, suggesting that chemotherapeutic treatment of the BM, including leukemia cells and cells in the leukemia microenvironment, induces high amounts of galectin-3. The gene discussed is LGALS3; the disease is leukemia.